Exosome BioSciences

Exosome Biosciences is a biotechnology company focused on harnessing the potential of exosomes for both therapeutic and diagnostic applications. The company utilizes its proprietary Exo-Target and Exo-Load platforms to engineer exosomes for the targeted delivery of therapeutic payloads, such as siRNA and small molecules, specifically for oncology and central nervous system (CNS) disorders. Its therapeutic pipeline includes pre-clinical programs for pancreatic cancer and glioblastoma, while its diagnostic division develops exosome-based liquid biopsy tests for early cancer detection. Headquartered in San Diego and with significant operations in Suzhou, China, Exosome Biosciences was a participant in the Illumina Accelerator and aims to advance precision medicine through its integrated exosome technology suite.